Home > Press > Carl Zeiss SMT, Calit2 Announce Nanotechnology Partnership
Carl Zeiss SMT, Calit2 Announce Nanotechnology Partnership
Irvine, CA | Posted on November 29, 2005
Carl Zeiss SMT, a global semiconductor and nanotechnology instrument manufacturer, and the California Institute for Telecommunications and Information Technology (Calit2) at the University of California, Irvine (UCI) will embark on a strategic alliance designed to provide a Southern California regional center of excellence for nanotechnology and biotechnology research, and advanced materials development and innovation.
Carl Zeiss SMT and Calit2 will establish the ZEISS Center of Excellence in the Calit2 building on the UCI campus. Carl Zeiss SMT will provide three fully equipped state-of-the-art electron microscopes worth approximately $2.5 million. The equipment will be shared by Calit2’s researchers, its industry partners and Carl Zeiss SMT´s application development team, who will use the lab to demonstrate and further enhance the instruments’ capabilities and application ranges for faculty users as well as Carl Zeiss SMT´s customers.
The new center will house a ZEISS 1540 EsB CrossBeam® workstation, a combination of ZEISS´ proprietary GEMINI® ultra-high resolution field-emission electron beam technology and focused ion beam (FIB) technology. Other equipment will include a ZEISS ULTRA 55 CDS ultra-high-resolution field-emission scanning electron microscope (FESEM) and a ZEISS EVO® multi- purpose scanning electron microscope (SEM) with variable chamber pressure capability, offering bio-scientists a unique opportunity to image cells in a representative wet environment. All three instruments are considered leading-edge technology in their respective fields.
Officials from Calit2 and Carl Zeiss SMT are equally enthusiastic about the opportunities provided by this new partnership. “We are proud to partner with Carl Zeiss SMT, a respected worldwide leader in semiconductor technology, and materials research and analysis equipment,” said UCI Chancellor Michael Drake. “Establishing this innovative center of excellence will create ongoing advantages for the many fields that benefit from cutting-edge nanotechnology research.”
The high-level microscopy offered by the new center also will be particularly useful to the aerospace, biomedical, semiconductor and energy systems industries located in the wider vicinity of the UCI campus.
“Carl Zeiss SMT believes strongly in the world-class research and capacity for innovation demonstrated by Calit2 and UC Irvine. The nanotechnology instrumentation suite and resources will immediately enable the pace of innovation to accelerate and the scope of this research to be greatly extended,” added Peter Clark, president and general manager of Carl Zeiss SMT Inc.
With this new center, Calit2 researchers will have the ability to conduct more advanced research in nanostructure materials research and engineering, benefiting researchers from physical sciences, biological sciences and engineering.
“We’re very pleased that these state-of-the-art electron microscopes will be available to Calit2 researchers and our industrial partners,” added Professor Albert F. Yee, Calit2 division director and materials scientist. “These instruments are essential for anyone performing nanotechnology and materials research, and with them, we’ll be able to extend the boundaries of these fields.”
“UCI and Southern California offer tremendous exposure for Carl Zeiss SMT, because this is a high technology growth area and a hotbed of bio-tech activity,” said Daniel R. Mumm, UCI assistant professor of chemical engineering and materials science, and one of the initiators of the alliance with Carl Zeiss SMT. “In addition to the ever-increasing number of start-up and mid-size technology companies located here, we have well-established aerospace and telecommunications industries that continually require access to ultra-high-resolution electron microscopy.”
While the new electron microscopy center itself is not unique within an academic environment, it will be one of only a couple in the country that exists in partnership with an instrument manufacturer. “The benefit to UCI is continuous upgrading of this key instrumentation suite, which will keep us at the forefront of advanced materials, nanotechnology and biotechnology research,” Mumm said. “Additionally, this partnership provides Carl Zeiss SMT with access to UC researchers and our industry associates who will push the existing technologies in new directions, potentially opening up new market applications for Carl Zeiss SMT.”
Delivery of the ZEISS equipment to Calit2 began in November and is expected to be complete in December.
About Carl Zeiss:
With a wide-ranging product portfolio, Carl Zeiss SMT meets the requirements of the key processes involved in nanotechnology and microchip production, making it one of the leading direct and indirect suppliers to the semiconductor industry. As an innovation leader in the field of Lithography Optics and optical and electron beam-based inspection and measuring systems, Carl Zeiss SMT generates important momentum for further development in the chip industry and nanotechnology. Together with its subsidiaries at locations in Germany, UK, USA and France, the international group of companies employs a total workforce of some 1,800 people. For the latest fiscal year ending Sept. 30, 2004, the company recorded Net Sales of EUR 560 Million. The stock corporation emerged from the Semiconductor Technology business group of Carl Zeiss as a 100 percent subsidiary on Oct.1, 2001.
For more information, please click here
About Calit2:
The California Institute for Telecommunications and Information Technology (www.calit2.net) integrates multidisciplinary intellectual capital and industry expertise to conduct cutting-edge research. More than 130 leading California computer, telecommunications, software and applications companies partner with Calit2 faculty participants to investigate areas as diverse as transportation, emergency response, public safety, the environment, security, health care, business, education, the arts and entertainment.
About the University of California, Irvine:
Celebrating 40 years of innovation, the University of California, Irvine is a top-ranked public university dedicated to research, scholarship and community service. Founded in 1965, UCI is among the fastest-growing University of California campuses, with more than 24,000 undergraduate and graduate students and about 1,400 faculty members. The second-largest employer in dynamic Orange County, UCI contributes an annual economic impact of $3 billion.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Nanoelectronics
Interdisciplinary: Rice team tackles the future of semiconductors Multiferroics could be the key to ultralow-energy computing October 6th, 2023
Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022
Reduced power consumption in semiconductor devices September 23rd, 2022
Atomic level deposition to extend Moore’s law and beyond July 15th, 2022
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
Aerospace/Space
Searching for dark matter with the coldest quantum detectors in the world July 5th, 2024
Under pressure - space exploration in our time: Advancing space exploration through diverse collaborations and ethical policies February 16th, 2024
Bridging light and electrons January 12th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||